Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)

Name: Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-30

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21) (English, HTML) HTML
Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21) (French, HTML) HTML

Related open data

Health Canada